Associated Papers
Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.
Tschongov T et al.
Frontiers in Immunology, 2024
38799460 (PubMed )
Supplement: DataSheet_1.docx
Epidemiology, Management, and Outcome of Atypical Hemolytic Uremic Syndrome in an Omani Cohort.
Al Riyami D et al.
Oman Medical Journal, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
Brocklebank V et al.
Blood, 2023
37369098 (PubMed )
Supplement: BLOOD_BLD-2022-018833R2-mmc1.pdf
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.
Acosta-Medina AA et al.
Blood Advances, 2023
35533258 (PubMed )
Supplement: BLOODA_ADV-2021-006416-mmc1.pdf
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab.
Tanaka K et al.
Pediatric Nephrology (berlin, Germany), 2021
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.
Piras R et al.
Frontiers in Medicine, 2020
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Greenbaum LA et al.
Kidney International, 2016
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH et al.
Journal of Thrombosis and Haemostasis : Jth, 2016
Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.
Kolev M et al.
Immunity, 2015
26084023 (PubMed )
Supplement: mmc1.pdf
Complement regulator CD46: genetic variants and disease associations.
Liszewski MK et al.
Human Genomics, 2015
A complementary component to atypical haemolytic uraemic syndrome.
Gandhi V et al.
Bmj Case Reports, 2013
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
Bresin E et al.
Journal of the American Society of Nephrology : Jasn, 2013
Age-related penetrance of hereditary atypical hemolytic uremic syndrome.
Sullivan M et al.
Annals of Human Genetics, 2011
Select a paper to view details